Maximum Low-density Lipoprotein Cholesterol Lowering Capacity Achievable With Drug Combinations. When 50 Plus 20 Equals 60

Rev Esp Cardiol (Engl Ed). 2016 Mar;69(3):342-3. doi: 10.1016/j.rec.2015.11.014. Epub 2016 Feb 5.

Authors

Lluis Masana¹, Daiana Ibarretxe², Nuria Plana²

Affiliations

¹ Unidad de Medicina Vascular y Metabolismo, Hospital Universitario Sant Joan, Universidad Rovira I Virgili, Instituto Investigación Sanitaria Pere Virgili (IISPV), CIBERDEM, Reus, Tarragona, Spain. Electronic address: luis.masana@urv.cat.
² Unidad de Medicina Vascular y Metabolismo, Hospital Universitario Sant Joan, Universidad Rovira I Virgili, Instituto Investigación Sanitaria Pere Virgili (IISPV), CIBERDEM, Reus, Tarragona, Spain.

PMID: 26856792
DOI: 10.1016/j.rec.2015.11.014

No abstract available

Publication types

Letter

MeSH terms

Anticholesteremic Agents / therapeutic use*
Cholesterol, LDL / blood
Drug Therapy, Combination
Ezetimibe / therapeutic use*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / blood
Hypercholesterolemia / drug therapy*
Treatment Outcome

Substances

Anticholesteremic Agents
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Ezetimibe